At 16.2% CAGR, the North America Neurosurgical Robotics Market is projected to be worth US$ 1,962.60 Million by 2028, says Business Market Insights

According to Business Market Insights’ research, the North America neurosurgical robotics market was valued at US$ 797.59 million in 2022 and is expected to reach US$ 1,962.60 million by 2028, registering an annual growth rate of 16.2% from 2022 to 2028. Rise in number of neurosurgical procedures and numerous advantages of neurosurgical robots encourage key players to develop innovative products are the critical factors attributed to the market expansion.

Brain and spinal surgeries require a high degree of technical proficiency, and robotic systems may play a crucial role in achieving desired outcomes. Over the traditional neurosurgeries, neurosurgical robots possess several advantages, including increased accuracy, better outcomes, sooner recovery, and shorter hospital stay. Minimally invasive robotic neurosurgery or robotic neurological minimally invasive surgery (RNMIS) represents a preferred option for the medical centers, surgeons, and patients. The use of robotics in neurosurgery eliminates mechanical errors, reduces operating duration, and provides the same or greater margins with minimal-access surgery. For instance, Renaissance Guidance System is a spine surgical robot developed by Mazor Robotics. The system helps improve accuracy and minimizes recovery time. It allows surgeons to pre-plan surgery in a 3-D field and guides them during surgery. The computer guidance allows superior accuracy, particularly if a patient’s anatomy shifts during surgery.

Moreover, owing to the increased advancements in neurosurgery, key players are working to grab a significant share in the neurosurgical robotics market. According to the data published by The Spine Market Group, Johnson & Johnson has around 16% of the spine market. Also, according to Johnson & Johnson CEO, the company is working to unlock the full potential and benefits of robotic and digital technologies. The growing demand for minimally invasive surgeries fueled the neurosurgical robotics market. In March 2019, Zimmer Biomet received FDA clearance of ROSA ONE Spine System for robotic-assisted surgeries. ROSA ONE Spine is a robotic and surgical navigation system designed to aid surgeons in performing thoracolumbar minimally invasive and complex spine procedures. Additionally, the approval of ROSA ONE Spine System strengthened the company's comprehensive ROSA ONE Brain Robotic system.

Furthermore, the growing adoption of robotic neurosurgeries help efficiently execute complicated tasks that require a high degree of accuracy. The robots assist surgeons in preoperative planning and executing the tasks during surgery with a high degree of dexterity. For instance, Remebot neurosurgical robot, developed by Beijing Bohui Weikang Technology Co., Ltd., integrates image processing and surgical planning, automatic positioning and navigation, and a multifunctional surgical operation platform. It assists doctors in completing nearly 100 operations in 12 categories with minimal invasiveness, precision, and efficiency. Thus, the broad range of advantages and applications of neurosurgical robots propel the neurosurgical robotics market.  

On the contrary, high installation costs of neurosurgical robotics hurdles the growth of North America neurosurgical robotics market.

• Based on component, the North America neurosurgical robotics market is segmented into equipment/system, accessories, and services. The equipment/system segment is further segmented into robot machines, navigation system, planner & simulators, and others. The accessories segment is anticipated to hold the largest share of the market in 2022 with a share of 45.6%, amassing US$ 363.89 million. It is projected to garner US$ 890.08 million by 2028 to expand at 16.1% CAGR during 2022–2028.

The North America neurosurgical robotics market, based on application, is segmented into spinal and cranial. Spinal application is further segmented into spinal fusion, laminectomy, disc replacement, discectomy, foraminotomy, and others. The cranial segment is also subsegmented into brain biopsy, thermal ablation of seizure, surgical treatment of movement disorders, and others. In 2022, the spinal segment is anticipated to hold the largest share of the market, with a share of 60.2%, amassing US$ 480.52 million. It is projected to garner US$ 1,208.60 million by 2028 to expand at 16.6% CAGR during 2022–2028.

The North America neurosurgical robotics market, based on surgery type, is segmented into open and minimally invasive. In 2022, the minimally invasive segment is anticipated to hold a larger share of the market in 2022 with a share of 81.5%, amassing US$ 645.31 million. It is projected to garner US$ 1,652.68 million by 2028 to expand at 17.0% CAGR during 2022–2028.

• Based on end user, the North America neurosurgical robotics market is segmented into hospitals, specialty centers, and others. In 2022, the hospitals segment is anticipated to hold the largest share of the market with a share of 62.3%, amassing US$ 496.69 million. It is projected to garner US$ 1,201.37 million by 2028 to expand at 15.9% CAGR during 2022–2028.

Our regional analysis states that the US captured 79.5% market share in 2022. It was assessed at US$ 633.99 million in 2022 and is likely to hit US$ 1,579.39 million by 2028, exhibiting a CAGR of 8.6% during the forecast period.

Key players dominating the North America neurosurgical robotics market are Accuray Incorporated; B. Braun Melsungen AG; Brainlab AG; Globus Medical, Inc.; Medtronic; NuVasive, Inc.; NuVasive, Inc; Renishaw plc; Synaptive Medical, Inc.; and Zimmer Biomet among others.

Below are listed a few key market developments by major players:

• In April 2022, Medtronic announced a partnership to interface Surgical Theater's SyncAR augmented reality (AR) technology with Medtronic's StealthStation S8 surgical navigation system.
• In Nov 2020, Medtronic announced that it had completed its friendly tender offer for France-based Medicrea International

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com